The Net Margin of Coherus BioSciences Inc (CHRS) is 10.68%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 10.68% |
| 2023-12-31 | -92.48% |
| 2022-12-31 | -138.29% |
| 2021-12-31 | -87.91% |
| 2020-12-31 | 27.78% |
| 2019-12-31 | 25.22% |
| 2018-12-31 | -14887.50% |
| 2017-12-31 | -66.96% |
| 2016-12-31 | -744.33% |